Sab Biotherapeutics, Inc.
SABS
Revenue
263.14k
▼-681.44k▼-72.14%
3 Months ChangeAssets
172.81M
▼-10.64M▼-5.80%
3 Months ChangeLiabilities
21.32M
▲2.94M▲16.01%
3 Months ChangeFree Cash Flow
-10.88M
▼-9.25M▼-568.65%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-12
Form 8-K
ID: 0001193125-26-010515
2026-01-07
Form 8-K
ID: 0001193125-26-005487
2025-12-29
Form 8-K
ID: 0001193125-25-335267
2025-11-14
Form 10-Q
ID: 0001193125-25-280572
2025-09-30
Form 8-K
ID: 0001193125-25-225119
2025-09-26
Form 8-K
ID: 0001193125-25-220721
2025-08-07
Form 10-Q
ID: 0000950170-25-104566
2025-07-21
Form 8-K
ID: 0000950170-25-097078
2025-07-17
Form 8-K
ID: 0000950170-25-096645
2025-05-09
Form 10-Q
ID: 0000950170-25-067554